
GE HealthCare Technologies Inc. company profile
$83.02+1.44%Close 13 Nov 2026 · Market value $37.71B
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a healthcare solutions provider that sells medical devices, consumable products, service capabilities, and AI-enabled cloud and software solutions. It operates four segments: Imaging, which covers molecular imaging, computed tomography, magnetic resonance, women's health, and X-ray; Advanced Visualization Solutions, which includes ultrasound and procedural guidance systems; Patient Care Solutions, which offers patient monitoring, diagnostic cardiology, maternal infant care, and anesthesia products; and Pharmaceutical Diagnostics, which supplies contrast media and radiopharmaceutical imaging agents. Its customers include hospitals, health systems, and researchers across public, private, academic, and government institutions. The company serves customers in over 160 countries and manufactures products at 44 facilities across 17 countries.
A summary of the business section of the company's latest annual report, filed 4 Feb 2026.
Company facts
| Ticker | GEHC · Nasdaq |
|---|
| Sector | Medical devices |
|---|
| Industry | Health Care Equipment |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 1932393 |
|---|
| Latest annual report | 10-K, filed 4 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Peter J. Arduini | President and CEO · Director | 510K · < 1% | Shares withheld for tax, 3 Sep 2026 |
|---|
| H. Lawrence Culp, Jr. | Director | 411K · < 1% | Grant or award, 7 May 2026 |
|---|
| Taha Kass-Hout | Chief Technology Officer | 147K · < 1% | Shares withheld for tax, 3 Sep 2026 |
|---|
| Frank R. Jimenez | GC & Corporate Secretary | 146K · < 1% | Shares withheld for tax, 3 Sep 2026 |
|---|
| James Saccaro | Chief Financial Officer | 137K · < 1% | Open-market purchase, 1 May 2026 |
|---|
| William J. Stromberg | Director | 14.3K · < 1% | Grant or award, 7 May 2026 |
|---|
| Rodney F. Hochman | Director | 13.6K · < 1% | Open-market purchase, 12 May 2026 |
|---|
| Anne T. Madden | Director | 13.6K · < 1% | Grant or award, 7 May 2026 |
|---|
| Risa Lavizzo-Mourey | Director | 10.2K · < 1% | Grant or award, 28 May 2025 |
|---|
| Catherine Lesjak | Director | 9.1K · < 1% | Grant or award, 7 May 2026 |
|---|
| Tomislav Mihaljevic | Director | 9.1K · < 1% | Grant or award, 28 May 2025 |
|---|
| Phoebe L. Yang | Director | 3.1K · < 1% | Open-market purchase, 8 May 2026 |
|---|
| Jeannette Bankes | CEO, Patient Care Solutions | 0 · 0% | Shares withheld for tax, 1 Sep 2026 |
|---|
| Kevin A. Lobo | Director | 0 · 0% | Open-market purchase, 22 May 2026 |
|---|
| Grogan William K | Chief Financial Officer | — | Grant or award, 14 Sep 2026 |
|---|
| Estrampes Catherine | Chief Commer. & Growth Officer | — | Shares withheld for tax, 3 Sep 2026 |
|---|
| Rackliffe Philip | CEO, AIS | — | Shares withheld for tax, 3 Sep 2026 |
|---|
| Newcomb George A. | Chief Accounting Officer | — | Shares withheld for tax, 3 Sep 2026 |
|---|
| O'Neill Kevin Michael | CEO, PDx | — | Shares withheld for tax, 3 Sep 2026 |
|---|
| Holton Adam Y | Chief People Officer | — | Shares withheld for tax, 3 Sep 2026 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
GEHC in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.